Get Started Search Icon

Favorite 5 Articles from the July 2010 Newsletter

Note: this content originally appeared in our June 2012 newsletter. More up-to-date research may be available, but the message is still the same!

Favorite 5 Articles from Recent Medical Journals

MS Drugs Are Criminally Expensive Failures

Association Between Use of Interferon Beta and Progression of Disability in Patients With Relapsing-Remitting Multiple Sclerosis (MS) by Afsaneh Shirani, published in the July 18, 2012 issue of the Journal of the American Medical Association, found that, Among patients with relapsing-remitting MS, administration of interferon beta was not associated with a reduction in progression of disability.” The investigators conclude